Your Article Summary
See Latest ArticlesSurgical management of metastatic bone disease
Journal of Bone and Joint Surgery, 06/05/09
Bickels J et al. - In a review of the surgical management of metastatic bone disease, it was concluded that detailed preoperative evaluation is required to assess the local extent of bone destruction and soft-tissue involvement, involvement of other skeletal sites, and overall medical and oncological status.
Methods- Metastatic bone disease is a major contributor to the deterioration of quality of life of pts with cancer.
- It causes pain, impending and actual pathological fractures, and loss of function and may be associated with considerable metabolic alterations.
- Operative treatment may be required for an impending or existing fracture and intractable pain.
- Goals of surgery are to provide local tumor control and allow immediate weight-bearing and function.
- Radiation therapy is often indicated postoperatively.
Related Articles
Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD)
Pediatric Nephrology, 11/11/09
Relevance Score: 87%
Methylene Blue Dye, an Accurate Dye for Sentinel Lymph Node Identification in Early Breast Cancer
Anticancer Research, 11/11/09
Relevance Score: 87%
Multiple symptoms of higher brain dysfunction caused by Marchiafava–Bignami disease in a patient with dermatomyositis
Rheumatology International, 11/16/09
Relevance Score: 80%
Today in Bone/Cartilage...keeping you current
Receive free subspecialty "5-minute updates" via email
mTOR/p70S6K Signal transduction pathway contributes to osteosarcoma progression and patients prognosis
Medical Oncology, 12/04/09
Oleanolic acid derivative Dex-OA has potent anti-tumor and anti-metastatic activity on osteosarcoma cells in vitro and in vivo
Investigational New Drugs, 12/04/09
Interventional radiology procedures in the treatment of bone metastasis
Bulletin du Cancer, 12/01/09